• Adamtsl3, MMP9 and Perineuronal-Net Plasticity

  2026-11-13

  A mouse visual-cortex study links Adamtsl3 loss to altered perineuronal-net composition, increased MMP9 activity, impaired PV-cell inhibition, and renewed adult ocular-dominance plasticity. Genetic and pharmacological experiments support an Adamtsl3–MMP9 pathway while leaving isoform-specific and translational questions unresolved.

• When Context Changes an MMP Result

  2026-11-13

  SB-3CT can be interpreted as a gelatinase probe, but the meaning of MMP inhibition depends on the biological model, upstream perturbation and readout. Research on Adamtsl3, perineuronal nets and adult visual-cortex plasticity illustrates why a pharmacological rescue does not automatically establish MMP9 exclusivity, clinical relevance or equivalence across disease contexts.

• Conserved Claustrum Subdivisions Across Mammals

  2026-11-12

  A comparative neuroanatomical study finds that claustrum-complex subdivisions can be recognized across five mammalian species by integrating topology, cytoarchitecture, and gene-expression patterns, despite major differences in size and shape.

• SIRT1, Type H Vessels, and Aging Bone

  2026-11-12

  Liu and colleagues link reduced SIRT1 activity with age-related loss of type H vasculature, impaired osteogenesis, and defective skeletal repair. Across senescent cell models and aged mice, pharmacological SIRT1 activation improved vascular and osteogenic readouts, with β-catenin/Wnt signaling and reciprocal endothelial–mesenchymal paracrine signaling implicated as downstream mechanisms. The findings are mechanistically informative but remain preclinical and pharmacologically bounded.

• Adamtsl3 Links MMP9 to Cortical Plasticity

  2026-11-11

  A mouse visual-cortex study identifies Adamtsl3 as an interneuron-associated regulator of perineuronal nets and supports MMP9 activity as one pathway connecting Adamtsl3 loss with altered PV-cell function and adult cortical plasticity.

• SIRT1, EX 527, and Aging Bone

  2026-11-11

  Liu and colleagues examined how age-associated SIRT1 decline affects the vascular and osteogenic compartments of bone. The study used SIRT1 activation and inhibition, cellular co-culture models, pathway analyses, and aged-mouse regeneration models to connect SIRT1 activity with type H vessels, β-catenin signaling, and skeletal repair.

• Tracking mRNA Antigen Expression In Vivo

  2026-11-10

  A PET reporter approach links translation of an mRNA-encoded antigen to whole-body imaging, revealing where expression occurs and how its signal changes over time in preclinical models.

• When Context Changes an MMP9 Result

  2026-11-10

  A mouse study of Adamtsl3, MMP9, perineuronal nets, and visual-cortical plasticity shows why a rescue result cannot be interpreted apart from cell type, developmental stage, molecular target, and readout. SB-3CT provides a useful gelatinase-inhibitor context, but its reported activity against both MMP-2 and MMP-9 limits claims of MMP9 exclusivity.

• When Context Changes an MMP9 Result

  2026-11-09

  An MMP9-associated rescue can mean different things depending on the genetic model, cell type, extracellular-matrix readout, and circuit outcome. The Adamtsl3 study in mouse visual cortex supports a mechanistic link between perineuronal-net regulation and adult plasticity, while the pharmacology of SB-3CT illustrates why gelatinase inhibition should not be treated as MMP9-exclusive or as evidence of clinical efficacy.

• When Context Changes an MMP9 Result

  2026-11-09

  The meaning of an MMP9 result depends on the model, intervention, and readout. In visual-cortex research, SB-3CT functioned as a pharmacological probe of an Adamtsl3–MMP9–perineuronal-net pathway, but that evidence does not establish clinical efficacy, human disease causation, or equivalence across cancer metastasis and cerebral-ischemia models.

• When Context Changes What EX 527 Means

  2026-11-08

  The meaning of EX 527 depends on the biological model, comparator, and readout. In aging-bone research, it functioned as a pharmacological SIRT1 loss-of-function probe, helping connect SIRT1 activity with vascular–osteogenic coupling while leaving important questions about specificity and translation unresolved.

• When Context Changes What MMP9 Inhibition Means

  2026-11-07

  A mouse visual-cortex study shows how genetic, molecular, circuit-level, and pharmacological contexts can give different meanings to an apparent MMP9-related result. SB-3CT is best interpreted as a gelatinase-pathway probe, not as standalone proof of a uniquely MMP9-dependent mechanism or therapeutic effect.

• Adamtsl3, MMP9 and Perineuronal-Net Plasticity

  2026-11-06

  A mouse visual-cortex study links Adamtsl3 loss in parvalbumin interneurons to altered perineuronal nets, increased MMP9 activity, impaired inhibitory function, and renewed adult ocular-dominance plasticity. Genetic, biochemical, electrophysiological, and pharmacological evidence supports an Adamtsl3–MMP9 pathway while remaining bounded to the tested models.

• Adamtsl3, MMP9, and Adult Cortical Plasticity

  2026-11-06

  A literature-focused analysis of how Adamtsl3 regulates perineuronal nets through MMP9 in mouse visual cortex, and what the associated SB-3CT pharmacology can—and cannot—establish about adult cortical plasticity and schizophrenia biology.

• SIRT1, Bone Repair, and the Type H Vessel Niche

  2026-11-05

  A recent study links SIRT1 activation to coordinated vascular and osteogenic improvement in aged bone models, while leaving important questions about pharmacological specificity, mechanism, durability, and translation unresolved.

8050 records 1/537 page Next 12345 下5页 Last page